Literature DB >> 21856181

Pushing the envelope beyond a centimeter in rectal cancer: oncologic implications of close, but negative margins.

Timothy L Fitzgerald1, Jason Brinkley, Emmanuel E Zervos.   

Abstract

BACKGROUND: The treatment of rectal cancer has improved significantly over the last century. Advances in surgical and adjuvant therapy coupled with a better understanding of the natural history have allowed for acceptance of progressively diminished margins for distal neoplasms. In order to better define oncologically safe distal margins, we performed a meta-analysis of the existing world's literature. STUDY
DESIGN: Studies were identified on Medline and ISI Web of Science using key words rectal cancer and margin. Studies were excluded if specific margins and local recurrence rates could not be extracted. All analyses were performed using Comprehensive Meta-Analysis Software (Biostat).
RESULTS: Twenty-one studies reported outcomes in relationship to distal margins. Seventeen studies, 4,885 patients, reported outcomes with margins of less than 1 cm. Analysis of all studies indicated a nonsignificant trend favoring greater margins. However, in order to understand distal margins in the context of current care standards, additional analyses were performed. Thirteen studies reported application of total mesorectal excision and/or radiation. There was no significant difference in local recurrence rates for margins less than 1 cm. In the 4 studies that reported neither total mesorectal excision nor radiation, a margin greater than 1 cm was favored. Increased recurrence rates and decreased survival were associated with positive final margins.
CONCLUSIONS: When total mesorectal excision is combined with radiotherapy, excellent local control can be expected with sphincter preservation for distal rectal cancers when margins are less than 1 cm, as long as final pathologic margins are negative.
Copyright © 2011 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21856181     DOI: 10.1016/j.jamcollsurg.2011.07.020

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  17 in total

1.  [Altering the therapeutic paradigm towards a distal bowel margin of < 1 cm in patients with low-lying rectal cancer: a systematic review and commentary].

Authors:  J Reibetanz; C T Germer
Journal:  Chirurg       Date:  2013-08       Impact factor: 0.955

2.  Changing operative strategy from abdominoperineal resection to sphincter preservation in T3 low rectal cancer after downstaging by neoadjuvant chemoradiation: a preliminary report.

Authors:  Khaled M Madbouly; Ahmed M Hussein
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

3.  Peritoneal Metastases: Prevention and Treatment.

Authors:  Paul H Sugarbaker
Journal:  Indian J Surg Oncol       Date:  2016-02-04

4.  Transanal excision with adjuvant therapy for pT1N0 rectal tumors with high-risk features offers equivalent survival to radical resection: A National Cancer Database analysis.

Authors:  Katherine A Hrebinko; Katherine M Reitz; Maryam K Mohammed; Ibrahim Nassour; Andrew R Watson; Kellie E Cunningham; David S Medich; James P Celebrezze; Jennifer M Holder-Murray
Journal:  J Surg Oncol       Date:  2021-10-27       Impact factor: 3.454

5.  Effects of surgical approach on short- and long-term outcomes in early-stage rectal cancer: a multicenter, propensity score-weighted cohort study.

Authors:  William C Kethman; Katherine E Bingmer; Asya Ofshteyn; Ronald Charles; Sharon L Stein; David Dietz; Emily Steinhagen
Journal:  Surg Endosc       Date:  2022-02-04       Impact factor: 3.453

Review 6.  Current Status of the Management of Stage I Rectal Cancer.

Authors:  Craig Howard Olson
Journal:  Curr Oncol Rep       Date:  2020-04-02       Impact factor: 5.075

7.  Neoadjuvant radiotherapy for rectal cancer: adherence to evidence-based guidelines in clinical practice.

Authors:  Timothy L Fitzgerald; Tithe Biswas; Kevin O'Brien; Emmanuel E Zervos; Jan H Wong
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

Review 8.  Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Tadao Tokoro
Journal:  Surg Today       Date:  2013-12-22       Impact factor: 2.549

Review 9.  Multidisciplinary treatment of rectal cancer in 2014: where are we going?

Authors:  Andrea Vignali; Paola De Nardi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

10.  A review of controversies in the management of colorectal cancers.

Authors:  S V S Deo; A S Kapali; M Gupta; N K Shukla
Journal:  Indian J Surg       Date:  2012-06       Impact factor: 0.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.